Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Joby Aviation
JOBY
|
$453M |
| 2 |
Datadog
DDOG
|
$423M |
| 3 |
Cloudflare
NET
|
$378M |
| 4 |
Mercado Libre
MELI
|
$311M |
| 5 |
Amazon
AMZN
|
$290M |
Top Sells
| 1 |
Tesla
TSLA
|
$750M |
| 2 |
Booking.com
BKNG
|
$484M |
| 3 |
Netflix
NFLX
|
$450M |
| 4 |
Spotify
SPOT
|
$372M |
| 5 |
Carvana
CVNA
|
$364M |
Sector Composition
| 1 | Consumer Discretionary | 27.35% |
| 2 | Technology | 24.66% |
| 3 | Healthcare | 18.87% |
| 4 | Communication Services | 12.6% |
| 5 | Financials | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
AutoZone
AZO
$70.1B
| $14.3M | 0.01% |
5,739
-16
| -0.3% | -$39.9K |
|
202
Quanterix
QTRX
$205M
| $14.2M | 0.01% |
631,897
| – | – |
|
203
CarMax
KMX
$9.07B
| $14.1M | 0.01% |
168,910
-927
| -0.5% | -$77.6K |
|
204
CRISPR Therapeutics
CRSP
$4.79B
| $13.7M | 0.01% |
243,594
-19,757
| -8% | -$1.11M |
|
205
Ionis Pharmaceuticals
IONS
$9.6B
| $13.6M | 0.01% |
330,346
-2,313
| -0.7% | -$94.9K |
|
206
QuantumScape
QS
$4.41B
| $13.4M | 0.01% |
1,680,976
+418,447
| +33% | +$3.34M |
|
207
LendingTree
TREE
$929M
| $12.5M | 0.01% |
564,870
+3,726
| +0.7% | +$82.4K |
|
208
iRobot
IRBT
$101M
| $12.2M | 0.01% |
269,636
| – | – |
|
209
First Industrial Realty Trust
FR
$6.87B
| $12M | 0.01% |
227,468
-221,084
| -49% | -$11.6M |
|
|
XYZ
210
Block, Inc.
XYZ
$46B
| $11.8M | 0.01% |
177,310
-627
| -0.4% | -$41.7K |
|
211
Visa
V
$676B
| $11.4M | 0.01% |
48,112
-3,761
| -7% | -$893K |
|
212
Sherwin-Williams
SHW
$90.4B
| $11.3M | 0.01% |
42,694
| – | – |
|
213
Eversource Energy
ES
$23.5B
| $11.2M | 0.01% |
157,972
+5,885
| +4% | +$417K |
|
214
Consolidated Edison
ED
$35B
| $10.8M | 0.01% |
118,966
-6,478
| -5% | -$586K |
|
215
Cooper Companies
COO
$13.2B
| $10.6M | 0.01% |
27,692
-2,218
| -7% | -$850K |
|
216
XP
XP
$9.4B
| $9.57M | 0.01% |
407,875
| – | – |
|
|
DCBO
217
Docebo
DCBO
$879M
| $9.46M | 0.01% |
238,813
+35,452
| +17% | +$1.4M |
|
218
Brookfield
BN
$96.8B
| $9.41M | 0.01% |
+279,711
| New | +$9.41M |
|
219
American Superconductor
AMSC
$2.22B
| $9.34M | 0.01% |
1,491,370
| – | – |
|
220
Cardlytics
CDLX
$46.6M
| $9.1M | 0.01% |
1,440,642
+13,701
| +1% | +$86.6K |
|
221
Oscar Health
OSCR
$4.5B
| $8.87M | 0.01% |
1,101,026
-4,271
| -0.4% | -$34.4K |
|
222
EverQuote
EVER
$850M
| $8.85M | 0.01% |
1,361,619
+3,180
| +0.2% | +$20.7K |
|
223
Expensify
EXFY
$175M
| $8.76M | 0.01% |
1,097,896
| – | – |
|
224
Sutro Biopharma
STRO
$83.3M
| $8.68M | 0.01% |
1,867,654
| – | – |
|
225
Veeva Systems
VEEV
$44.3B
| $8.48M | 0.01% |
42,911
-311
| -0.7% | -$61.5K |
|